CAS 252977-51-8 – 7-(1,1-Dimethylethyl)-6-((1-ethy… | In Stock

CAS No.

252977-51-8

MDL No.

MFCD29921350

C₂₀H₂₂FN₇O

395.40

InChI Key

QKIWQBLNTSQOLY-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
1 mg	99.75% ;	$187	In Stock
5 mg	99.75% ;	$372	In Stock
10 mg	99.75% ;	$536	In Stock
25 mg	99.75% ;	$941	In Stock
50 mg	99.75% ;	$1320	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

99.75% ;

$187

In Stock

5 mg

99.75% ;

$372

In Stock

10 mg

99.75% ;

$536

In Stock

25 mg

99.75% ;

$941

In Stock

50 mg

99.75% ;

$1320

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	252977-51-8
Product Name	7-(1,1-Dimethylethyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1,2,4-triazolo(4,3-b)pyridazine

Associated Conditions

generalized anxiety disorder·Anxiety·schizophrenia

* The information provided here is compiled from public sources and is for reference only.

7-(1,1-Dimethylethyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1,2,4-triazolo(4,3-b)pyridazine

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Documentation

7-(1,1-Dimethylethyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1,2,4-triazolo(4,3-b)pyridazine

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Related Articles

Pharmacological Properties of DOV 315,090, an ocinaplon metabolite.

In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist.

Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.

Documentation